---
$id: https://graph.org.ai/products/commodity/51112102
$type: Product
source: UNSPSC
code: "51112102"
title: "Palifermin"
class: "51112100"
classTitle: "Antineoplastic agents, antineoplastic agent immunotoxins and antineoplastic keratinocyte growth factors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Palifermin

**UNSPSC Code**: 51112102
**Class**: [Antineoplastic agents, antineoplastic agent immunotoxins and antineoplastic keratinocyte growth factors](Antineoplastic agents, antineoplastic agent immunotoxins and antineoplastic keratinocyte growth factors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic fibroblast growth factor with the molecular formula C729H1156N204O207S10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QMS40680K6, more generally known as palifermin. European Medicines Agency schedules palifermin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21058. The term PALIFERMIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, no. 3, 2002, list 48. Most nations schedule Palifermin under HS 29332990 and SITC 51573. SMILES:. As of Q4 2014, PALIFERMIN remains the US FDA Preferred Term for this commodity. . Palifermin bears US NLM identifiers UMLS ID C0677829 and NCI Concept Code C2455.

